TY - JOUR
T1 - Paper-Based Surface-Enhanced Raman Scattering Lateral Flow Strip for Detection of Neuron-Specific Enolase in Blood Plasma
AU - Gao, Xuefei
AU - Zheng, Peng
AU - Kasani, Sujan
AU - Wu, Steven
AU - Yang, Feng
AU - Lewis, Sara
AU - Nayeem, Sara
AU - Engler-Chiurazzi, Elizabeth B.
AU - Wigginton, Jane G.
AU - Simpkins, James W.
AU - Wu, Nianqiang
N1 - Publisher Copyright:
© 2017 American Chemical Society.
PY - 2017/9/19
Y1 - 2017/9/19
N2 - An inexpensive and disposable paper-based lateral flow strip (PLFS) has been developed as an immunoassay, in which surface-enhanced Raman scattering (SERS) is utilized for sensing signal transduction. The Au nanostar@Raman Reporter@silica sandwich nanoparticles are developed as the SERS probes, which is the key to the high sensitivity of the device. Compared with a colorimetric PLFS, the SERS-PLFS exhibits superior performance in terms of sensitivity and limit of detection (LOD) in a blood plasma-containing sample matrix. In addition, the SERS-PLFS has been successfully used for detection of neuron-specific enolase (NSE), a traumatic brain injury (TBI) protein biomarker, in diluted blood plasma samples, achieving a LOD of 0.86 ng/mL. Moreover, the SERS-PLFS was successfully employed to measure the NSE level in clinical blood plasma samples taken from deidentified TBI patients. This work demonstrates that the SERS-PLFS has great potential in assisting screening of TBI patients in the point-of-care setting.
AB - An inexpensive and disposable paper-based lateral flow strip (PLFS) has been developed as an immunoassay, in which surface-enhanced Raman scattering (SERS) is utilized for sensing signal transduction. The Au nanostar@Raman Reporter@silica sandwich nanoparticles are developed as the SERS probes, which is the key to the high sensitivity of the device. Compared with a colorimetric PLFS, the SERS-PLFS exhibits superior performance in terms of sensitivity and limit of detection (LOD) in a blood plasma-containing sample matrix. In addition, the SERS-PLFS has been successfully used for detection of neuron-specific enolase (NSE), a traumatic brain injury (TBI) protein biomarker, in diluted blood plasma samples, achieving a LOD of 0.86 ng/mL. Moreover, the SERS-PLFS was successfully employed to measure the NSE level in clinical blood plasma samples taken from deidentified TBI patients. This work demonstrates that the SERS-PLFS has great potential in assisting screening of TBI patients in the point-of-care setting.
UR - http://www.scopus.com/inward/record.url?scp=85029575211&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029575211&partnerID=8YFLogxK
U2 - 10.1021/acs.analchem.7b03015
DO - 10.1021/acs.analchem.7b03015
M3 - Article
C2 - 28817769
AN - SCOPUS:85029575211
SN - 0003-2700
VL - 89
SP - 10104
EP - 10110
JO - Analytical Chemistry
JF - Analytical Chemistry
IS - 18
ER -